comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 11:38:23 - browse：4

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Laying a path for careers in science

focus

Wikipedia

WSS

CDC panel: People 65 and older should get a Covid spring booster shot

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Readout Newsletter: Beam, Prozac, "TechBio" and more

'Vaccine

leisure time

comprehensive

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Medicare details structure of new drug price negotiation program

Children’s Hospital revives plan for pedestrian bridge

Sports medicine is finally prioritizing gender equality

Neuroscience renaissance leads to new crop of psychiatric drugs

New air purifier tech could be key to improving indoor air quality

Study fuels hope CAR

State Dept. review finds Biden bears some blame for Afghanistan failures

Ohio train derailment: Experts on toxic chemical risks

entertainment

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Study fuels hope CAR

Laying a path for careers in science

Medicare isn't yet testing food as medicine

Pfizer is about to make a big push in cancer. Will investors listen?

focus

Wikipedia

Wikipedia

knowledge